Synthaverse S.A.
BML | WAR
Overview
Corporate Details
- ISIN(s):
- PLBMDLB00018 (+3 more)
- LEI:
- 259400OWZM67D079S374
- Country:
- Poland
- Address:
- LUBLIN UNIWERSYTECKA 10, 20-029 LUBLIN
- Website:
- https://synthaverse.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
We are a global pharmaceutical company whose goal is to provide the best, innovative and unique solutions for medicine. Our work is based on scientific and health knowledge. Along with our expert approach, it allows us to create reliable and unique products. We are constantly developing our competences. One of our leading achievements is on advancing field of immunotherapy. We manufacture one of the few drugs used internationally in the oncological immunotherapy of bladder cancer. We have also created an anti-tuberculosis vaccine, which is used to vaccinate all newborns in the country. It is widely used all over the world. Scientific knowledge and many years of experience in the cultivation of bacterial strains have allowed us to create one of the best probiotics on the market - Lakcid®, which is one of the few probiotic drugs available in the world.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-05 15:54 |
Regulatory News Service
zal03_pdf_852875.pdf
|
Polish | 4.5 KB | |
| 2025-07-05 15:54 |
Regulatory News Service
zal02_pdf_852849.pdf
|
Polish | 4.3 KB | |
| 2025-07-05 15:54 |
Regulatory News Service
zal01_pdf_852819.pdf
|
Polish | 4.5 KB | |
| 2025-07-05 15:54 |
Regulatory News Service
zal04_pdf_852681.pdf
|
Polish | 4.4 KB | |
| 2025-07-05 15:54 |
Regulatory News Service
zal05_pdf_852546.pdf
|
Polish | 4.5 KB | |
| 2025-07-05 15:54 |
Regulatory News Service
Powiadomienie o transakcjach na akcjach (zawarcie umów pożyczek akcji) Emitenta…
|
Polish | 1.1 KB | |
| 2025-07-04 18:03 |
Regulatory News Service
zal03_tresc_projektowanych_zmian_statutu_NWZA_31.07.2025.pdf
|
Polish | 134.1 KB | |
| 2025-07-04 18:03 |
Regulatory News Service
zal02_Ogloszenie_o_zwolaniu_NWZA_31.07.2025.pdf
|
Polish | 206.8 KB | |
| 2025-07-04 18:03 |
Regulatory News Service
zal01_PROJEKTY_UCHWAL_NWZA_na_31.07.20252.pdf
|
Polish | 303.5 KB | |
| 2025-07-04 18:03 |
Regulatory News Service
Ogłoszenie o zwołaniu Nadzwyczajnego Walnego Zgromadzenia - Content (PL)
|
Polish | 3.2 KB | |
| 2025-07-03 18:50 |
Regulatory News Service
Finansowanie strategicznych projektów Emitenta - Content (PL)
|
Polish | 6.8 KB | |
| 2025-07-03 17:21 |
Regulatory News Service
Internacjonalizacja i aktualizacja strategii rozwoju Emitenta - Content (PL)
|
Polish | 9.3 KB | |
| 2025-06-26 09:14 |
Regulatory News Service
zal01_ESPI_wykaz_akcjonariuszy_posiadajacych_co_najmniej_5__glosow_na_WZA_25.06…
|
Polish | 18.8 KB | |
| 2025-06-26 09:14 |
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
|
Polish | 345 bytes | |
| 2025-06-25 17:43 |
Declaration of Voting Results & Voting Rights Announcements
zal01_UCHWALY_PODJETE_NA_WZA_25.06.20252.pdf
|
Polish | 181.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |